Concept information
Preferred term
Biopharmaceutical New Technologies
Definition(s)
- BioNTech SE ; short for Biopharmaceutical New Technologies is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. (Wikipédia)
Broader concept(s)
Synonym(s)
- BioNTech
- BioNTech SE
Creator
- Patricia Fener
In other languages
-
French
-
BioNTech
-
BioNTech SE
URI
http://data.loterre.fr/ark:/67375/C0X-N040Q6CK-1
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}